This article is more than 5 years old. Information may no longer be current.

FDA approves PureVision Toric lenses

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

ROCHESTER, N.Y. — A toric contact lens from Bausch & Lomb has been granted regulatory approval for vision correction in people with astigmatism, according to a press release from the company.

B&L’s PureVision Toric lens is made with balafilcon A, a patented silicone hydrogel material. The lens is approved for the correction of refractive ametropia with astigmatism up to 5 D. It is designed for monthly replacement and approved for either daily wear or up to 30-day continuous wear, according to the company.

Already available in Europe, Canada and Australia, the PureVision Toric is expected to be launched in the United States during the summer.